Enorama Pharma AB (publ) (STO:ERMA)
1.185
+0.455 (62.33%)
Oct 15, 2026, 5:29 PM CET
Enorama Pharma AB Market Cap
Enorama Pharma AB has a market cap or net worth of 88.39 million as of October 15, 2026. It is the 44,617th most valuable company in the world and the 675th biggest in Sweden. Its market cap has decreased by 52.60% in one year.
Market Cap
88.39M
Enterprise Value
86.29M
Revenue
1.45M
Global Rank
Country Rank
#675 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since June 10, 2016, Enorama Pharma AB's market cap has increased from 35.83M to 88.39M, an increase of 146.71%. That is a compound annual growth rate of 9.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 88.39M | -37.96% |
| Dec 30, 2025 | 142.46M | -29.89% |
| Dec 30, 2024 | 203.19M | 77.51% |
| Dec 29, 2023 | 114.47M | 308.04% |
| Dec 30, 2022 | 28.05M | -83.60% |
| Dec 30, 2021 | 171.01M | -12.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cereno Scientific AB | 1.12B |
| Dicot Pharma AB | 822.77M |
| EQL Pharma AB | 674.75M |
| Cinclus Pharma Holding AB | 602.20M |
| Moberg Pharma AB | 535.03M |
| Enzymatica AB | 412.65M |
| Orexo AB | 218.01M |
| Klaria Pharma Holding AB (publ.) | 123.23M |